Status
Conditions
Treatments
About
Children with abnormal weight development of BMI will be given either placebo or a probiotic protein formula and measures of weigh gain during a 3-mont treatment will be conducted
Full description
In this study, children with abnormal weight development of BMI will be recruited and the gut microbiota will be modified using one of there treatment schedules. The subjects will be divided into three groups 1) receiving a daily drink with protein drink with a probiotic Lactobacillus rhamnosus GG or 2) placebo drink and/or 3) drink with Lactobacillus rhamnosus GG.
The children will give a faecal sample in the beginning and at the end and similarly also a blood sample. The faecal sample will be used for analysis of microbiota and differences in microbiota between the groups. Blood samples will be analysed for obesity related biomarkers.
Body weight is followed at home and at frequent intervals of the study and analyses made for overweight related biomarkers.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria: 2-5 year old child with early weight gain and abnormal BMI, parental concern on weight gain/development
Exclusion Criteria:Medicines influencing gastric or intestinal function, antibiotic treatment during the last 6 months, use of specific probiotics
Primary purpose
Allocation
Interventional model
Masking
45 participants in 3 patient groups, including a placebo group
Loading...
Central trial contact
Erika Isolauri, MD, PhD; seppo Salminen, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal